Heparin Sodium (CAS 9041-08-1) serves as a vital pharmaceutical intermediate, playing a critical role in the manufacturing of anticoagulant medications. Its well-established efficacy in preventing and treating blood clots makes it a sought-after ingredient for companies developing drugs aimed at managing thromboembolic disorders.

As a mucopolysaccharide, Heparin Sodium's inherent anticoagulant properties are harnessed to create a wide range of therapeutic products. The biochemical studies surrounding its mechanism of action, particularly its potent antithrombotic effects via inhibition of thrombin and Factor Xa, provide a strong foundation for its use in drug development. The requirement for high purity (u226599.00%) and a consistent physical form (white or almost white crystalline powder) underscores the importance of reliable sourcing for this intermediate.

Manufacturers in China are significant suppliers of Heparin Sodium, offering a crucial link in the global pharmaceutical supply chain. These suppliers are equipped to produce Heparin Sodium that meets rigorous international standards, ensuring its suitability for pharmaceutical applications. For businesses looking to buy Heparin Sodium as a pharmaceutical intermediate, partnering with these manufacturers provides access to a stable supply at competitive prices.

The consistent availability and quality of Heparin Sodium are essential for the uninterrupted production of life-saving anticoagulant medications. Understanding its properties and procurement channels is key for any entity involved in the pharmaceutical industry requiring this critical compound.